Atlas Trials

Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia

Clinical trial NCT07453836 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07453836
Sponsor
China Immunotech (Beijing) Biotechnology Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Autoimmune Hemolytic Anemia
Start date
2026-03-18
Primary completion
2027-03-18
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.